Bloom Health, a healthcare advisory firm, has raised $7.5m in series B round convertible preferred stock.
According to the company’s regulatory filing the money came from three investors to complete the targeted round.
In January, Bloom raised $5m in its series A round from BlueCross BlueShield Venture Partners, a $116m corporate venturing fund sponsored by the Blue Cross and Blue Shield Association managed by venture capital and incubation firm Sandbox Industries.
At that time, Paul Brown, managing director of BlueCross BlueShield Venture Partners, said: "Bloom Health’s innovative approach helps companies and their employees get smarter about how they pay for and select health benefits."